Diagnosis and Management of Retinal Vasoproliferative Tumors

Timely intervention is vital for retinal vasoproliferative tumors to prevent vision loss, as their treatment options evolve with technological advances.

By
Arun D. Singh, MD
Soumaya Bouhout, MD
September 1, 2025
7 min

Retinal Physician

Overview

Retinal vasoproliferative tumors (VPTs) are rare vascular lesions that can lead to significant vision loss if not promptly diagnosed and treated. Advances in imaging and treatment have improved outcomes, yet challenges remain in managing these tumors, particularly in secondary cases associated with other retinal diseases.

Background

VPTs are acquired lesions that typically present in the third or fourth decade of life and can be mistaken for other retinal tumors. Early recognition and intervention are crucial to prevent vision loss. Understanding the clinical features, differential diagnoses, and management strategies is essential for ophthalmologists.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

VPTs are characterized by globular yellow-pink masses with associated exudation and subretinal fluid.
Management strategies include observation for small, asymptomatic tumors and various treatments based on tumor size and activity.
Laser photocoagulation is effective for tumors ≤1.5 mm, while larger tumors may require cryotherapy or radiation therapy.
Secondary VPTs are often associated with conditions like uveitis or retinal degeneration.
Fluorescein angiography shows early hyperfluorescence and late diffuse leakage in VPTs.

Clinical Implications

Ophthalmologists should be vigilant in differentiating VPTs from other retinal vascular tumors to ensure appropriate management. Timely intervention can significantly improve visual outcomes, especially in cases with active lesions.

Conclusion

VPTs represent a unique challenge in retinal pathology, necessitating a thorough understanding of their presentation and management to optimize patient outcomes.